KIMA - Korea International Medical Association

HOME
About us
KIMA Excellence

ABOUT US

KIMA EXCELLENCE

Shared Korean Medical Service

From the 60,000 foreign patents who visited Korea for medical treatment in 2009. the number has increased annually by about 23.5% reaching 1 million from 199 countries in 2019.

Most Visited Country in the world

(Cumulative annual no. of patients from 2009 to 2017)
world map
199 Countries

*Annual no. of patients: Equivalent to the number plus the number of days of a patient’s multiple medical treatments and hospitalization.

*Actual No. of patients: No. of patients by hospital except multiple medical treatments and visits.

  • KIMA NEWS

    Asan Medical Center makes history in liver transplantation - Seven thousand liver transplantations

    MORE     AMC set a world record of 7,000 liver transplantations as the liver transplantation team successfully performed a living-donor liver transplantation(LDLT) on July 17, 2020. AMC has made history through endless challenges by becoming the world’s first medical institution to perform in modified right lobe LDLT, dual graft LDLT, and ABO-incompatible liver transplantation and Korea’s first to perform pediatric LDLT, ABO-incompatible pediatric LDLT, and simultaneous liver-heart transplantation. Significantly, in January 1999, AMC developed the surgical technique of modified right lobe LDLT for the first time in the world, increasing the number of LDLTs done a year to more than 100 from about 30. The success rate has also significantly improved from 70% to over 95%.

5-year cancer survival rates

For major cancer types, decreased mortality width increased survival rates due to advanced medical technologies such as robots.

world map

  • Thyroid cancer

    100%

  • Breast cancer

    92.3%

  • Cervical cancer

    79.9%

  • Colorectal cancer

    76.3%

  • Stomach cancer

    75.4%

  • Rectal cancer

    71.0% Top1 among OECD member countries

※ International Comparison of Cancer Survival Rates, NCIC, 2017

5-year posttransplant survival rates

World’s top success rates of organ transplantations such as liver and kidney transplants from living donors.

world map

  • Liver transplant

    100%

  • Heart transplant

    92.3%

  • Pancreas transplant

    76.3%

  • Kidney transplant

    75.4%

  • Mortality from ischaemic heart disease

    Lowest among OECD member countries

※ Korean Network for organ sharing (KONOS) Statistical yearbook, 2015

  • KIMA NEWS

    Samsung Medical Center becomes Asia’s first ventricular arrhythmia surgery training center

    MORE     To designate a ventricular arrhythmia surgery training center, Johnson & Johnson Medical Devices Companies (JJMDC) selects qualified specialists and medical institutions with surgical experiences and skills and grants their qualifications. Since the opening of the Ventricular Arrhythmia Clinic in 2015, SMC continues to offer specialized treatment, focusing on radiofrequency catheter ablation (RFA). The clinical pathologists and radiologists participating in arrhythmia surgery in the clinic are arrhythmia specialists, who have been certified for their competency in Cardiac Electrophysiology for the Allied Professional as a part of the International Board of Heart Rhythm Examiners (IBHRE).
  • KIMA NEWS

    Sevrance Hospital has been named as the top cancer research institution in Korea at the global scientific journal Nature.

    MORE     Yonsei University Medical Center (Yoon, Do-heum, director of medical center) ranked first in research performance among domestic cancer hospitals in the '2020 Top 100 Healthcare Institutions in Cancer Research' released by Nature, one of the world's top three scientific journals. Yonsei University Medical Center ranked 75th place among the world's top 100 medical institutions.
  • KIMA NEWS

    Local prostate cancer can now be treated through electric pulse instead of surgeries by Seoul St. Mary’s Hospital(SSMH)

    MORE     A new type of treatment for local prostate cancer has been introduced. The treatment does not require surgery but can kill cancer cells with a strong electric pulse. The research team of Lee Ji Youl and Park Yong Hyun of the Catholic University of Korea, Seoul St. Mary’s Hospital, introduced NanoKnife for the first time in Asia. Lee’s team of researchers introduced the new health technology to overcome the limits of treating prostate cancer, which is rapidly increasing among men. The team is practicing new technology in earnest to help treat prostate cancer patients. NanoKnife is a type of local treatment which target prostate patients who are in low or medium risk. 2 to 6 thin electrode needles emit millions of electric pulses per second around cancer cells and destroy them with nano-scale holes. The holes trigger the cancer cells’ molecule balance to collapse and make them die gradually, which eventually eliminates cancer.
CONTACT US

CONTACT US